We came across a bullish thesis on Automatic Data Processing, Inc. on Compounding Dividends’s Substack by TJ Terwilliger. In this…
Read More
Celsius Holdings, Inc. Q4 2025 Earnings Call Summary
Celsius Holdings, Inc. Q4 2025 Earnings Call Summary – Moby Achieved record full-year revenue of $2.5 billion by transitioning from…
Read More
Dollar Tree (DLTR) Rallied Following the Divestiture of Its Family Dollar Business
The London Company, an investment management company, released its fourth-quarter 2025 investor letter for its “The London Company Mid Cap…
Read More
Alight (ALIT) Faces Sharp Price Target Cut from BofA on Weak Q1 Forecast
Alight, Inc. (NYSE:ALIT) is included among the 13 Most Promising Long-Term Stocks to Buy According to Hedge Funds. Alight (ALIT)…
Read More
RXO, Inc. (RXO): A Bear Case Theory
We came across a bearish thesis on RXO, Inc. on DF Research’s Substack by Keith Dalrymple. In this article, we…
Read More
Do You Have Conviction in the Durability of ServiceTitan’s (TTAN) Profit Cycle
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Mid Cap Fund”. A copy of…
Read More
Here’s Why Madison Large Cap Fund Exited Fiserv (FISV)
Madison Investments, an investment advisor, released its fourth-quarter 2025 investor letter for the “Madison Large Cap Fund”. A copy of…
Read More
Lake Street Adjusts Aquestive Therapeutics, Inc. (AQST) Valuation Model on Expected Approval Delay
Aquestive Therapeutics, Inc. (NASDAQ:AQST) is among the 7 Oversold Pharma Stocks to Buy Now. Lake Street Adjusts Aquestive Therapeutics, Inc.…
Read More
Does Veracyte (VCYT) Offer Both Strength and Opportunity?
Brown Capital Management, an investment management company, released its fourth quarter 2025 investor letter for “The Brown Capital Management Small…
Read More
Synopsys Stock: Analyst Estimates & Ratings
With a market cap of $84.2 billion, Synopsys, Inc. (SNPS) is a leading provider of design automation and design IP…
Read More
